
### [NCIT:C2919](http://purl.obolibrary.org/obo/NCIT_C2919)
**Label:** Prostate Adenocarcinoma

**Subclasses:** [NCIT:C6813](http://purl.obolibrary.org/obo/NCIT_C6813) (Prostate Ductal Adenocarcinoma), [NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern), [NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern), [NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern), [NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant), [NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant), [NCIT:C8945](http://purl.obolibrary.org/obo/NCIT_C8945) (Metastatic Prostatic Adenocarcinoma), [NCIT:C27916](http://purl.obolibrary.org/obo/NCIT_C27916) (Poorly Differentiated Prostate Adenocarcinoma), [NCIT:C27905](http://purl.obolibrary.org/obo/NCIT_C27905) (Well Differentiated Prostate Adenocarcinoma), [NCIT:C27906](http://purl.obolibrary.org/obo/NCIT_C27906) (Moderately Differentiated Prostate Adenocarcinoma), [NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation), [NCIT:C5596](http://purl.obolibrary.org/obo/NCIT_C5596) (Prostate Acinar Adenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.75%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40295](http://purl.obolibrary.org/obo/NCIT_C40295) (Bartholin Gland Adenoid Cystic Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40293](http://purl.obolibrary.org/obo/NCIT_C40293) (Bartholin Gland Squamous Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40290](http://purl.obolibrary.org/obo/NCIT_C40290) (Vestibular Micropapillomatosis))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40287](http://purl.obolibrary.org/obo/NCIT_C40287) (Vulvar Warty Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40286](http://purl.obolibrary.org/obo/NCIT_C40286) (Vulvar Basaloid Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40284](http://purl.obolibrary.org/obo/NCIT_C40284) (Vulvar Keratinizing Squamous Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40275](http://purl.obolibrary.org/obo/NCIT_C40275) (Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40272](http://purl.obolibrary.org/obo/NCIT_C40272) (Vaginal Undifferentiated Sarcoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40271](http://purl.obolibrary.org/obo/NCIT_C40271) (Low Grade Endometrioid Stromal Sarcoma of the Vagina))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 37.63%


